Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

71.650
+1.4502.07%
Volume:7.92M
Turnover:564.36M
Market Cap:90.71B
PE:54.83
High:72.400
Open:70.200
Low:69.100
Close:70.200
52wk High:85.500
52wk Low:43.500
Shares:1.27B
HK Float Shares:1.27B
Volume Ratio:1.00
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.307
ROE:17.05%
ROA:8.60%
PB:7.25
PE(LYR):54.83
PS:13.08

Loading ...

WuXi XDC Announces $100 Million Share Buyback

MT Newswires Live
·
May 19

WUXI XDC Plans Up to $100 Million Share Buyback Using Internal Reserves

Stock News
·
May 18

WuXi XDC proposes on-market share purchase of up to US$100 million for employee schemes

Bulletin Express
·
May 18

WuXi XDC Cayman Inc - to Use up to $100 Mln for Open Market Share Purchase for Share Schemes

THOMSON REUTERS
·
May 18

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

WuXi XDC lifts issued share count by 1.77 million in April; authorised capital unchanged and public float intact

Bulletin Express
·
May 06

Global In Focus With 3 Stocks Considered By Analysts As Undervalued

Simply Wall St.
·
May 01

BIODLINK-B Shares Surge Over 9% Following Appointment of WUXI XDC CEO to Key Roles

Stock News
·
Apr 29

TOT Biopharm names Jincai Li chair after Fu resigns

Reuters
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

Stock Track | WuXi XDC Soars 5.09% Intraday on Strong Annual Earnings and Sector-Wide Rally

Stock Track
·
Apr 28

WuXi XDC 2025 ESG Report: Revenue Up 46.70%, GHG Emission Intensity Down 70%

Bulletin Express
·
Apr 24

WuXi XDC 2025年度业绩速览:营收同比增长46.7%,多项业务与治理结构持续优化

Bulletin Express
·
Apr 24

WuXi XDC publishes 2025 annual report

Reuters
·
Apr 24

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

CMB International Reports Moderate Recovery in Healthcare Sector Risk Appetite, Recommends Six Stocks Including Hansoh Pharma

Stock News
·
Apr 20

Assessing WuXi XDC Cayman (SEHK:2268) Valuation After New Akari Therapeutics ADC Partnership

Simply Wall St.
·
Apr 10

Akari CEO says WuXi XDC partnership accelerates AKTX-101 IND toward late 2026

Reuters
·
Apr 09

WUXI XDC Issues 1.203 Million Shares Following Option Exercise

Stock News
·
Apr 08

WuXi XDC approves 4.85 million restricted shares for 425 staff under 2024 scheme

Bulletin Express
·
Apr 08